Home

IDEXX Laboratories, Inc. - Common Stock (IDXX)

396.37
-14.39 (-3.50%)
NASDAQ · Last Trade: Apr 4th, 11:32 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to IDEXX Laboratories, Inc. - Common Stock (IDXX)

Neogen Corporation NEOG -3.14%

Neogen Corporation competes with IDEXX Laboratories by providing diagnostic and animal safety solutions for the agricultural and veterinary sectors. Both companies focus on diagnostics, but Neogen is more diversified into food safety and biosecurity, giving it a unique niche. While IDEXX focuses heavily on pet diagnostics, Neogen covers a broader range of food safety products, thus distinguished in the competitive landscape. IDEXX maintains a competitive advantage due to its more established brand loyalty within veterinary professionals, but Neogen's expertise in food safety keeps it a solid contender.

Thermo Fisher Scientific Inc. TMO -6.83%

Thermo Fisher Scientific is a heavyweight in the life sciences sector and competes with IDEXX Laboratories in diagnostics through its vast range of laboratory instruments and reagents. Although Thermo Fisher's primary focus hasn't been exclusive to veterinary diagnostics, its technological capabilities can be directed towards animal health diagnostics, which poses a potential threat to IDEXX. IDEXX holds a competitive advantage in its specialized veterinary market, with products tailored specifically to pet healthcare, while Thermo Fisher offers a broader range of life sciences products that could appeal to academic and research markets.

Vetoquinol SA

Vetoquinol SA is a global player in the animal health market, primarily focused on veterinary pharmaceuticals and supplements. While IDEXX Labs leads in veterinary diagnostics, Vetoquinol's strength lies in its well-established pharmaceutical products aimed at improving animal health and productivity. The competition between these two companies is not as fierce compared to IDEXX and Zoetis, as IDEXX still maintains a stronghold in the diagnostics space, giving it a competitive advantage, especially in the rapidly evolving technology for pet healthcare diagnostics.

Zoetis Inc. ZTS -4.94%

Zoetis Inc. specializes in animal health products, making it a direct competitor to IDEXX Laboratories, which focuses on diagnostics and other biological products for pets and livestock. Both companies offer veterinary services and diagnostics but differ in product range; while IDEXX has a strong emphasis on diagnostic tests, Zoetis provides a wider array of pharmaceuticals and vaccines. The competition is fierce in the animal health sector as both companies aim to innovate and expand their offerings, with Zoetis often viewed as having a competitive advantage through its established relationships with veterinarians and broader global market reach.